Why Tailored CMC Solutions are Critical for Biologics vs Small Molecules
Summary: Understanding the differences between biologics and small molecules is essential in the CMC drug development process. Engaging pharma consulting companies ensures that tailored strategies address unique manufacturing, formulation, and regulatory challenges. This guide explains why one-size-fits-all approaches fail and how customized solutions improve compliance, efficiency, and market readiness. Pharmaceutical products are broadly categorized into…